August 14, 2012
INDUSTRY, Calif.AIDP Inc. received two patents for magnesium compositions and uses for cognitive function and neurological disorders. The company distributes Magtein magnesium L-threonate, a cognitive health ingredient.
The recently awarded patents protect Magteins magnesium compositions and their use for any magnesium L-threonate-containing food, nutritional supplements and drugs. Magtein is a magnesium-based functional ingredient designed to improve memory, focus and overall cognitive health, including ameliorating the effects of a neurological disorder. AIDP began distributing Magtein in June 2011.
The products are targeted at people suffering from loss of cognitive function, loss of memory, Alzheimer's disease, depression, attention deficit hyperactivity disorder, Amyotrophic lateral sclerosis (ALS), Parkinson's disease, migraine, anxiety disorder and mood disorder.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Probi study finds subjects’ brains worked better under stress with probioticSep 29, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023